A ‘druggable’ mechanism of tau protein pathology could lead to new treatment for dementia
Alzheimer's disease
-
-
Another early-onset Alzheimer’s gene mutation is found in a Colombian family, and is traced back to Africa
-
New insight into the mechanism of tau protein aggregation could lead to better in vitro models for neurodegenerative disease research
-
Alzheimer’s researchers begin to unravel how the protein tau transitions from soluble liquid to solid fibrous tangle
-
UCSB neuroscientist Kenneth Kosik examines the importance of basic cell biology research
-
The documentary “Can Alzheimer’s be Stopped?” screens at UCSB’s Pollock Theater, followed by a panel discussion
-
A new book by UCSB neuroscientist Kenneth S. Kosik offers strategies for reducing the risk of Alzheimer’s disease
-
Multiple drug development efforts for treating Alzheimer’s would operate simultaneously
